SWS Hemodialysis Care Co., Ltd. (SHA:688410)
China · Delayed Price · Currency is CNY 16.86
-0.55 (-3.16%)
At close: May 8, 2026
SWS Hemodialysis Care Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 847.27 | 806.91 | 567.1 | 689.96 | 381.89 | 283.1 |
Other Revenue | - | - | 0.18 | 0.15 | 0.12 | 0.17 |
| 847.27 | 806.91 | 567.27 | 690.11 | 382.01 | 283.28 | |
Revenue Growth (YoY) | 42.53% | 42.24% | -17.80% | 80.65% | 34.86% | 11.35% |
Cost of Revenue | 403.83 | 401.59 | 320.46 | 354.38 | 217.09 | 168.83 |
Gross Profit | 443.44 | 405.32 | 246.81 | 335.73 | 164.93 | 114.44 |
Selling, General & Admin | 207.06 | 187.33 | 157.6 | 132.21 | 97.7 | 80.34 |
Research & Development | 61.24 | 62.78 | 54.24 | 37.67 | 23.13 | 17.74 |
Other Operating Expenses | -29.06 | -27.94 | 4.55 | -17.35 | -8.68 | -4.77 |
Operating Expenses | 239.24 | 222.17 | 214.65 | 155.93 | 115.29 | 95.22 |
Operating Income | 204.2 | 183.15 | 32.16 | 179.8 | 49.64 | 19.23 |
Interest Expense | - | - | -0.28 | -0.16 | -0.8 | -1.61 |
Interest & Investment Income | 8.82 | 9.2 | 25.56 | 25.72 | 2.61 | 4.8 |
Currency Exchange Gain (Loss) | - | - | 0.93 | 0.68 | 0.74 | -0.2 |
Other Non Operating Income (Expenses) | -15.07 | -15.86 | -0.58 | 2.67 | -1.05 | -0.74 |
EBT Excluding Unusual Items | 197.95 | 176.5 | 57.79 | 208.71 | 51.14 | 21.48 |
Gain (Loss) on Sale of Investments | 11.03 | 9.47 | 9.14 | 10.79 | 0.78 | - |
Gain (Loss) on Sale of Assets | 0.02 | 0.03 | -0.28 | 0.45 | -0.34 | 0.04 |
Asset Writedown | -22.78 | -21.24 | -8.01 | - | - | -0.05 |
Other Unusual Items | - | - | 9.78 | - | 11.77 | 0.59 |
Pretax Income | 186.22 | 164.75 | 68.42 | 219.95 | 63.36 | 22.05 |
Income Tax Expense | 24.41 | 20.51 | 4.42 | 27.74 | 6.46 | 3.91 |
Earnings From Continuing Operations | 161.81 | 144.24 | 64 | 192.21 | 56.9 | 18.14 |
Minority Interest in Earnings | 1.54 | 1.64 | 6.89 | 2.29 | 2.33 | 1.33 |
Net Income | 163.36 | 145.89 | 70.89 | 194.5 | 59.24 | 19.47 |
Net Income to Common | 163.36 | 145.89 | 70.89 | 194.5 | 59.24 | 19.47 |
Net Income Growth | 121.77% | 105.80% | -63.55% | 228.34% | 204.20% | -5.55% |
Shares Outstanding (Basic) | 318 | 318 | 320 | 321 | 321 | 241 |
Shares Outstanding (Diluted) | 318 | 318 | 320 | 321 | 321 | 241 |
Shares Change (YoY) | -0.26% | -0.57% | -0.49% | 0.03% | 33.29% | 10.47% |
EPS (Basic) | 0.51 | 0.46 | 0.22 | 0.61 | 0.18 | 0.08 |
EPS (Diluted) | 0.51 | 0.46 | 0.22 | 0.61 | 0.18 | 0.08 |
EPS Growth | 122.35% | 106.99% | -63.37% | 228.25% | 128.22% | -14.50% |
Free Cash Flow | 107.98 | 151.87 | 59.97 | -47.97 | 232.9 | 4.69 |
Free Cash Flow Per Share | 0.34 | 0.48 | 0.19 | -0.15 | 0.72 | 0.02 |
Dividend Per Share | - | - | 0.100 | 0.269 | - | - |
Dividend Growth | - | - | -62.76% | - | - | - |
Gross Margin | 52.34% | 50.23% | 43.51% | 48.65% | 43.17% | 40.40% |
Operating Margin | 24.10% | 22.70% | 5.67% | 26.05% | 13.00% | 6.79% |
Profit Margin | 19.28% | 18.08% | 12.50% | 28.18% | 15.51% | 6.87% |
Free Cash Flow Margin | 12.75% | 18.82% | 10.57% | -6.95% | 60.97% | 1.65% |
EBITDA | 224.77 | 203.35 | 50.88 | 196.03 | 63.94 | 32.99 |
EBITDA Margin | 26.53% | 25.20% | 8.97% | 28.41% | 16.74% | 11.65% |
D&A For EBITDA | 20.57 | 20.2 | 18.73 | 16.23 | 14.3 | 13.76 |
EBIT | 204.2 | 183.15 | 32.16 | 179.8 | 49.64 | 19.23 |
EBIT Margin | 24.10% | 22.70% | 5.67% | 26.05% | 13.00% | 6.79% |
Effective Tax Rate | 13.11% | 12.45% | 6.46% | 12.61% | 10.19% | 17.72% |
Revenue as Reported | - | - | 567.27 | 690.11 | 382.01 | 283.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.